Get all the latest news on coronavirus and more delivered daily to your inbox.Sign up here.Former Food and Drug Administration (FDA) Commissioner Dr. Scott Gottlieb weighed in Sunday on the use of antimalarial drug hydroxychloroquine as a possible treatment for the novel coronavirus and reacted to several businesses in Georgia reopening during the pandemic. Speaking on CBS’ “Face the Nation” on Sunday, Gottlieb said that he doesn’t think doctors should be using hydroxychloroquine “outside of protocols at this point, given the fact that we’ve had now accruing evidence demonstrating really no benefit and some indication that it could be causing harm.”Gottlieb made the comments two days after the U.S. Food and Drug Administration (FDA) warned against the use of two antimalarial drugs that have been touted as possible treatments for the new coronavirus following reports of “serious heart rhythm problems” in COVID-19 patients treated with the medications.The drugs hydroxychloroquine and chloroquine should not be used outside of a hospital or clinical setting, the agency said, especially when used alongside the antibiotic azithromycin, also known as a Z-Pak.”The FDA is aware of reports of serious heart rhythm problems in patients with COVID-19 treated with hydroxychloroquine or chloroquine, often in combination with azithromycin,” the FDA wrote on its website. The medications, which

Continue To Full Article